BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 30844311)

  • 1. Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells.
    Wang W; Hind T; Lam BWS; Herr DR
    FASEB J; 2019 Jun; 33(6):7180-7191. PubMed ID: 30844311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergence of Intracellular Trafficking of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Receptor 3 in MCF-7 Breast Cancer Cells and MCF-7-Derived Stem Cell-Enriched Mammospheres.
    Sukocheva OA; Hu DG; Meech R; Bishayee A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing.
    Serriere-Lanneau V; Teixeira-Clerc F; Li L; Schippers M; de Wries W; Julien B; Tran-Van-Nhieu J; Manin S; Poelstra K; Chun J; Carpentier S; Levade T; Mallat A; Lotersztajn S
    FASEB J; 2007 Jul; 21(9):2005-13. PubMed ID: 17341687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine 1-Phosphate Receptors in Cerebral Ischemia.
    Gaire BP; Choi JW
    Neuromolecular Med; 2021 Mar; 23(1):211-223. PubMed ID: 32914259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment.
    Chua XY; Ho LTY; Xiang P; Chew WS; Lam BWS; Chen CP; Ong WY; Lai MKP; Herr DR
    Neuromolecular Med; 2021 Mar; 23(1):47-67. PubMed ID: 33180310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression.
    Kim ES; Cha Y; Ham M; Jung J; Kim SG; Hwang S; Kleemann R; Moon A
    Oncogene; 2014 Jul; 33(27):3583-93. PubMed ID: 23955082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
    Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
    Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.
    Shida D; Fang X; Kordula T; Takabe K; Lépine S; Alvarez SE; Milstien S; Spiegel S
    Cancer Res; 2008 Aug; 68(16):6569-77. PubMed ID: 18701480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.
    Arikawa K; Takuwa N; Yamaguchi H; Sugimoto N; Kitayama J; Nagawa H; Takehara K; Takuwa Y
    J Biol Chem; 2003 Aug; 278(35):32841-51. PubMed ID: 12810709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition.
    Milara J; Navarro R; Juan G; Peiró T; Serrano A; Ramón M; Morcillo E; Cortijo J
    Thorax; 2012 Feb; 67(2):147-56. PubMed ID: 22106015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
    Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
    Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
    Wang S; Liang Y; Chang W; Hu B; Zhang Y
    Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.
    Watson C; Long JS; Orange C; Tannahill CL; Mallon E; McGlynn LM; Pyne S; Pyne NJ; Edwards J
    Am J Pathol; 2010 Nov; 177(5):2205-15. PubMed ID: 20889557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
    Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate signaling through its receptor S1P
    Andrieu G; Ledoux A; Branka S; Bocquet M; Gilhodes J; Walzer T; Kasahara K; Inagaki M; Sabbadini RA; Cuvillier O; Hatzoglou A
    Sci Signal; 2017 Mar; 10(472):. PubMed ID: 28351953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
    Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
    Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
    Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
    Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity.
    Martin JL; Lin MZ; McGowan EM; Baxter RC
    J Biol Chem; 2009 Sep; 284(38):25542-52. PubMed ID: 19633297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.